The Two Mannose 6-Phosphate Binding Sites of the Insulin-like Growth Factor-II/Mannose 6-Phosphate Receptor Display Different Ligand Binding Properties

Patricia G. Marron‐Terada, Mary A. Brzycki-Wessell, Nancy Dahms

Journal of Biological Chemistry · 1998 · 36 citations · 48 references

DOIFull text

Open access

Concepts

Abstract

The two mannose 6-phosphate (Man-6-P) binding sites of the insulin-like growth factor-II/mannose 6-phosphate receptor (IGF-II/MPR) have been localized to domains 1–3 and 7–9, and studies have shown that Arg435 in domain 3 and Arg1334 in domain 9 are essential for Man-6-P binding. To determine whether the IGF-II/MPR containing a single Man-6-P binding site is functional, clonal mouse L cell lines stably transfected with either mutant bovine IGF-II/MPR cDNA, containing substitutions at position 435 and/or 1334, or the wild type receptor cDNA were assayed for their ability to sort lysosomal enzymes to the lysosome. Mutant receptors containing a single Man-6-P binding site were ∼50% less efficient than the wild type receptor in the overall targeting of lysosomal enzymes to the lysosome. Mutant receptors containing a substitution at Arg1334 (Dom9Ala), in contrast to those containing a substitution at Arg435(Dom3Ala), were unable to target cathepsin D and β-hexosaminidase to the lysosome. Equilibrium binding assays using125I-labeled β-glucuronidase demonstrated that Dom3Ala and Dom9Ala had aKd of 2.0 and 4.3 nm, respectively. In addition, Dom3Ala, unlike Dom9Ala, was unable to completely dissociate from ligand under acidic pH conditions. These data indicate that the two Man-6-P binding sites of the IGF-II/MPR are not functionally equivalent. The two mannose 6-phosphate (Man-6-P) binding sites of the insulin-like growth factor-II/mannose 6-phosphate receptor (IGF-II/MPR) have been localized to domains 1–3 and 7–9, and studies have shown that Arg435 in domain 3 and Arg1334 in domain 9 are essential for Man-6-P binding. To determine whether the IGF-II/MPR containing a single Man-6-P binding site is functional, clonal mouse L cell lines stably transfected with either mutant bovine IGF-II/MPR cDNA, containing substitutions at position 435 and/or 1334, or the wild type receptor cDNA were assayed for their ability to sort lysosomal enzymes to the lysosome. Mutant receptors containing a single Man-6-P binding site were ∼50% less efficient than the wild type receptor in the overall targeting of lysosomal enzymes to the lysosome. Mutant receptors containing a substitution at Arg1334 (Dom9Ala), in contrast to those containing a substitution at Arg435(Dom3Ala), were unable to target cathepsin D and β-hexosaminidase to the lysosome. Equilibrium binding assays using125I-labeled β-glucuronidase demonstrated that Dom3Ala and Dom9Ala had aKd of 2.0 and 4.3 nm, respectively. In addition, Dom3Ala, unlike Dom9Ala, was unable to completely dissociate from ligand under acidic pH conditions. These data indicate that the two Man-6-P binding sites of the IGF-II/MPR are not functionally equivalent. Mannose 6-phosphate receptors (MPRs) 1The abbreviations used are: MPRmannose 6-phosphate receptorCD-MPRcation-dependent MPRMan-6-Pmannose 6-phosphateIGF-IIinsulin-like growth factor-IIWTwild typeFBSfetal bovine serumPAGEpolyacrylamide gel electrophoresisGlu-6-Pglucose 6-phosphateDMEMDulbecco's modified Eagle's mediumMES2-(N-morpholino)ethanesulfonic acid.1The abbreviations used are: MPRmannose 6-phosphate receptorCD-MPRcation-dependent MPRMan-6-Pmannose 6-phosphateIGF-IIinsulin-like growth factor-IIWTwild typeFBSfetal bovine serumPAGEpolyacrylamide gel electrophoresisGlu-6-Pglucose 6-phosphateDMEMDulbecco's modified Eagle's mediumMES2-(N-morpholino)ethanesulfonic acid. play an essential role in the delivery of lysosomal enzymes to the lysosome in higher eukaryotic cells (1von Figura K. Hasilik A. Annu. Rev. Biochem. 1986; 55: 167-193Crossref PubMed Scopus (636) Google Scholar, 2Dahms N.M. Lobel P. Kornfeld S. J. Biol. Chem. 1989; 264: 12115-12118Abstract Full Text PDF PubMed Google Scholar, 3Kornfeld S. Annu. Rev. Biochem. 1992; 61: 307-330Crossref PubMed Scopus (931) Google Scholar, 4Munier-Lehmann H. Mauxion F. Hoflack B. Biochem. Soc. Trans. 1996; 24: 133-136Crossref PubMed Scopus (45) Google Scholar). Newly synthesized acid hydrolases acquire mannose 6-phosphate (Man-6-P) recognition markers on theirN-linked oligosaccharides in the Golgi, which allows the enzymes to bind with high affinity to MPRs. The receptor-lysosomal enzyme complex is transported from the trans-Golgi network to an acidified prelysosomal compartment where the low pH causes the complex to dissociate. The lysosomal enzymes are delivered to the lysosome, while the receptors recycle back to the Golgi or move to the plasma membrane, where they function to internalize exogenous ligands. mannose 6-phosphate receptor cation-dependent MPR mannose 6-phosphate insulin-like growth factor-II wild type fetal bovine serum polyacrylamide gel electrophoresis glucose 6-phosphate Dulbecco's modified Eagle's medium 2-(N-morpholino)ethanesulfonic acid. mannose 6-phosphate receptor cation-dependent MPR mannose 6-phosphate insulin-like growth factor-II wild type fetal bovine serum polyacrylamide gel electrophoresis glucose 6-phosphate Dulbecco's modified Eagle's medium 2-(N-morpholino)ethanesulfonic acid. Two distinct MPRs have been identified and extensively characterized. The bovine insulin-like growth factor-II/MPR (IGF-II/MPR) is a 270-kDa membrane glycoprotein that can bind two distinct classes of ligands: Man-6-P-containing proteins and IGF-II, a nonphosphorylated polypeptide hormone (5Tong P.Y. Tollefsen S.E. Kornfeld S. J. Biol. Chem. 1988; 263: 2585-2588Abstract Full Text PDF PubMed Google Scholar, 6Waheed A. Braulke T. Junghans U. von Figura K. Biochem. Biophys. Res. Commun. 1988; 152: 1248-1254Crossref PubMed Scopus (57) Google Scholar). The bovine IGF-II/MPR consists of a 2269-residue extracytoplasmic region, a single transmembrane region, and a 163-residue carboxyl-terminal cytoplasmic domain (7Lobel P. Dahms N.M. Kornfeld S. J. Biol. Chem. 1988; 263: 2563-2570Abstract Full Text PDF PubMed Google Scholar). The extracytoplasmic ligand-binding region has a repetitive structure due to the presence of 15 contiguous domains, each ∼150 amino acids in length. The second receptor, the 46-kDa bovine cation-dependent MPR (CD-MPR), exhibits optimal ligand binding in the presence of divalent cations (8Hoflack B. Kornfeld S. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 4428-4432Crossref PubMed Scopus (83) Google Scholar, 9Ma Z. Grubb J.H. Sly W.S. J. Biol. Chem. 1992; 267: 19017-19022Abstract Full Text PDF PubMed Google Scholar), shares sequence homologies with each of the 15 repeating domains of the IGF-II/MPR (10Dahms N.M. Lobel P. Breitmeyer J. Chirgwin J.M. Kornfeld S. Cell. 1987; 50: 181-192Abstract Full Text PDF PubMed Scopus (96) Google Scholar), and is expressed along with the IGF-II/MPR in most cell types (11Wenk J. Hille A. von Figura K. Biochem. Int. 1991; 23: Google Scholar). of the ligand binding of the MPRs has that the IGF-II/MPR while the of Man-6-P polypeptide P.Y. Kornfeld S. J. Biol. Chem. 1989; 264: Full Text PDF PubMed Google Scholar, P.Y. Kornfeld S. J. Biol. Chem. 1989; 264: Full Text PDF PubMed Google Scholar). the a in N.M. Kornfeld S. J. Biol. Chem. 1989; 264: Full Text PDF PubMed Google Scholar, Biochem. Biophys. PubMed Scopus Google Scholar), the of the that of the two Man-6-P binding is not whether Man-6-P binding sites are for the targeting of lysosomal enzymes to the lysosome. studies and of of the receptor have localized the two Man-6-P binding sites of the IGF-II/MPR to domains 1–3 and domains B. Dahms N.M. Kornfeld S. J. Biol. Chem. 1991; Full Text PDF PubMed Google Scholar, N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). studies have demonstrated an role for the in domain 3 and domain 9 In a single Man-6-P binding site 1–3 or domains or Man-6-P binding sites of the with or in the of ligand binding affinity of the was in the domains Man-6-P binding the ability to bind to a affinity N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). In the have containing Man-6-P binding site a single at position 435 or and have their ability to target lysosomal enzymes to the lysosome in their affinity for ligand in indicate that containing a single Man-6-P binding site are ∼50% less efficient than the wild type IGF-II/MPR in the overall targeting of lysosomal In addition, of the of lysosomal the binding affinity to and the of ligand at acidic pH that the two Man-6-P binding sites of the IGF-II/MPR are not functionally equivalent. The were or fetal bovine serum from was a of of the L cells and the were Lobel of and of cells were Sly of cells were a of cathepsin D was Kornfeld of to substitution at position 435 and/or was N.M. J. Biol. Chem. Full Text PDF PubMed Google and the The and mutant bovine IGF-II/MPR were the Proc. Natl. Acad. Sci. U. S. A. 1988; PubMed Scopus Google Scholar), which a IGF-II/MPR mouse L cell L was Kornfeld S. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). were in containing at in The L cells were transfected with of the B. A. T. S. Cell. Full Text PDF PubMed Scopus Google Scholar). were for to each were and were for receptor and J. Lobel P. J. Biol. Chem. Full Text PDF PubMed Google Scholar). were for and in and J. Lobel P. J. Biol. Chem. Full Text PDF PubMed Google Scholar). stably transfected cells at were in containing for or in containing for with containing and the cells were for on in and containing and each of and The of in the was the the the of the and mutant IGF-II/MPR stably transfected cells were for a for or The cell were with an and The were and and the in the receptor was a and The of receptor for each was N.M. J. Biol. Chem. Full Text PDF PubMed Google that with bovine the were for with and containing bovine serum and The receptor was and a and the were to bovine IGF-II/MPR was used the and was on each gel N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). transfected cells were with and the cell were to N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). The glucose 6-phosphate and Man-6-P were for the bovine IGF-II/MPR N.M. J. Biol. Chem. Full Text PDF PubMed Google or with acid and The were with an In and mutant from stably transfected L cells were to affinity with the that to the and Man-6-P the were with and pH was the J. Biol. Chem. Full Text PDF PubMed Google to of β-glucuronidase was with of Kornfeld S. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google that gel on β-glucuronidase was on an IGF-II/MPR affinity The β-glucuronidase was to the and mutant from stably transfected L cells enzyme affinity (8Hoflack B. Kornfeld S. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 4428-4432Crossref PubMed Scopus (83) Google were with of for at Dahms N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). The complex was the of of and pH (5Tong P.Y. Tollefsen S.E. Kornfeld S. J. Biol. Chem. 1988; 263: 2585-2588Abstract Full Text PDF PubMed Google Scholar). IGF-II/MPR were used a of binding. In binding was of the The were and Acad. Sci. Scopus Google Scholar). cell lines in were at in bovine serum Man-6-P for to dissociate from the The cells were with in bovine serum for at The medium was and the was with acid. The were on the were two with of acid and the cells were in The cells transfected with were used a for binding. The was the of the and the Cell. Full Text PDF PubMed Scopus Google Scholar). The were in the presence of Man-6-P to cell from lysosomal enzymes P. K. Kornfeld S. Cell. 1989; Full Text PDF PubMed Scopus Google Scholar). transfected cells were for a for The cells were in and the of was the of the medium was bovine IGF-II/MPR affinity Kornfeld S. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar). the were with in Man-6-P in The were with acid and to and the was an transfected cells were for a for of cells and medium were with cathepsin at Kornfeld S. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar). Man-6-P was to each to a of to cathepsin D to in the J. Lobel P. J. Biol. Chem. Full Text PDF PubMed Google Scholar). The were and and the of cathepsin D in the cells and medium was a cells were with and for at to lysosomal enzymes in the H. Sly W.S. PubMed Google the medium was and the cells were The cells were in and of cell and medium were with either or in to determine the of β-hexosaminidase and J.H. Sly W.S. J. 82: Google Scholar). L cells Kornfeld S. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar), was to the IGF-II/MPR from the to the binding The unlike the P.Y. Kornfeld S. J. Biol. Chem. 1989; 264: Full Text PDF PubMed Google Scholar), can bind A. J. Biol. Chem. Full Text PDF PubMed Google Scholar, J. Biol. Chem. Full Text PDF PubMed Google Scholar). and mutant were cell an affinity with lysosomal which Man-6-P to Kornfeld S. J. Biol. Chem. Full Text PDF PubMed Google Scholar). The were and with and the Man-6-P were extensively to The of IGF-II/MPR was To that was Man-6-P was than that used for the binding were to In the of in the Man-6-P was the of or mutant were with of The MPR and ligand were with an that was to a of the were and The and were and the was a of ligand in each β-glucuronidase was from the MPRs at for with The were binding and of the To binding were that demonstrated that β-glucuronidase not with the of the IGF-II/MPR and that and were to of the were to that binding was that β-glucuronidase binding was on the of receptor and that Man-6-P was to of the β-glucuronidase to the To determine whether mutant containing a single Man-6-P binding than two are of targeting lysosomal enzymes to the lysosome, of which identified Arg435 in domain 3 and Arg1334 in domain 9 essential for high affinity Man-6-P binding N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). was used to an to substitution at position 435 or to with Man-6-P binding a mutant was that substitutions at essential to a receptor that the ability to bind the of the bovine IGF-II/MPR that were expressed in mouse L a cell that Kornfeld S. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar), in the of the of lysosomal enzymes the of to mutant 435 of Man-6-P binding in domain 3 and/or domain 9 were with which has been shown to Man-6-P binding N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). transfected cell lines were for each and the and of of in a in domain 3 and/or domain 9 were with which has been shown to Man-6-P binding N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). transfected cell lines were for each and the and of of To that the mutant receptors their ability to bind Man-6-P-containing proteins and IGF-II, to function in and to in the cells was studies a domains of the IGF-II/MPR that with a single either at Arg435 or Arg1334 their ability to bind to a affinity while the at Arg435 and Arg1334 not N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). To determine the receptor, from stably transfected cells were to affinity The and mutant receptors with Man-6-P binding site or were on the affinity and with of the containing the mutant to the These that the IGF-II/MPR is to the receptors in that of Arg435 and Arg1334 the ability to bind that two are essential for high affinity Man-6-P binding. To the of the binding binding assays were on the of the binding not demonstrated a of and for the Dom3Ala, and which are to of for the bovine IGF-II/MPR (5Tong P.Y. Tollefsen S.E. Kornfeld S. J. Biol. Chem. 1988; 263: 2585-2588Abstract Full Text PDF PubMed Google Scholar). These that the binding which has been localized to domain N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar, B. A. Braulke T. von Figura K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), has not been the single amino acid substitution in either domain 3 or domain To that the mutant receptors were expressed on the cell and in of stably transfected cells were with and the cell and was The were to and for the Dom3Ala, Dom9Ala, and that are expressed on the cell and internalize at a the of the Dom3Ala, Dom9Ala, and was to and respectively. that the single amino acid substitution in domain 3 or domain 9 not the or structure of the To the ability of mutant with Man-6-P binding site to target lysosomal enzymes to the lysosome, medium from clonal cell lines with for a was to affinity on with IGF-II/MPR of distinct Man-6-P-containing proteins was to each of the clonal cell L cells transfected with the which not a Man-6-P binding a of lysosomal enzymes with cells transfected with In clonal cell lines the Dom3Ala, or or of the enzymes cells transfected with These data indicate that with Man-6-P binding site are less efficient than the IGF-II/MPR in the overall targeting of lysosomal enzymes to the lysosome. of the demonstrated that clonal cell lines the Dom3Ala, or Dom9Ala receptor of the lysosomal These data indicate the Dom3Ala and Dom9Ala are in their ability to target lysosomal enzymes the two receptors in their ability to target lysosomal enzymes to the lysosome To cells transfected with and mutant were for their ability to target the lysosomal enzymes cathepsin and of cathepsin D to the lysosome can the of a that from the of the to the Hasilik A. von Figura K. J. Biol. PubMed Scopus Google Scholar). The of a in which cell and were from cells with for and for to the synthesized cathepsin D to and either to the lysosome or are shown in 3 and the data are in 3 B. L cells transfected with or with the of their cathepsin In clonal cell lines of the IGF-II/MPR of cathepsin D the with in a cell of IGF-II/MPR of The of clonal cell lines the Dom3Ala that expressed at of of the of cathepsin D to The of the Dom9Ala not in a in the of cathepsin These data indicate that containing Man-6-P binding site are less efficient than the receptor in targeting cathepsin D to the lysosome. To mutant with Man-6-P binding site sort and were a L cells transfected with or with the mutant of their cell lines of the IGF-II/MPR of β-hexosaminidase the with in a clonal cell of of cell lines that the Dom3Ala the of β-hexosaminidase to a In clonal cell lines that the Dom9Ala were to cells and of their These that receptors with a in domain in contrast to receptors with a in domain target lysosomal enzyme to the lysosome. The and of β-glucuronidase were for the stably transfected mouse L cells transfected with or with the mutant of their lysosomal cell lines of the IGF-II/MPR of β-glucuronidase in the with in clonal cell lines of of of clonal cell lines that the Dom3Ala a in the of β-glucuronidase to or on the of receptor clonal cell of Dom9Ala of the of β-glucuronidase the medium to These data that mutant with Man-6-P binding site can target β-glucuronidase to the lysosome, expressed at less than they are not efficient the The of and lysosomal enzyme that with Man-6-P binding site are not efficient in lysosomal enzymes the The data that the of on the enzyme and the of the Man-6-P binding In to the in due to a in the affinity for or mutant were and with of Man-6-P IGF-II/MPR with a with or receptor at to The of the IGF-II/MPR at of In of mutant receptors at and the with less than These data that receptors with Man-6-P binding site have a affinity for than the The that the of the at a of Man-6-P than the Dom3Ala receptor, that the two Man-6-P binding sites have for To in the binding affinity of the Man-6-P binding the affinity of the Dom3Ala, and Dom9Ala for an ligand was The ligand was the lysosomal which has been and has a of A. Sly W.S. J. Biol. Chem. Full Text PDF PubMed Google for and mutant were with of of the binding demonstrated a of 2.0 and 4.3 for the Dom3Ala, and Dom9Ala of data the of Acad. Sci. Scopus Google Scholar), in a that to and of β-glucuronidase of receptor for the Dom3Ala, and Dom9Ala respectively. These data are with the of of IGF-II/MPR for the lysosomal P.Y. Kornfeld S. J. Biol. Chem. 1989; 264: Full Text PDF PubMed Google Scholar). These indicate that the mutant receptors are to the receptor in their affinity for the mutant receptors from each in that Dom9Ala has affinity for β-glucuronidase than The targeting of lysosomal enzymes MPRs is a that the binding of ligand in the Golgi and the of the lysosomal enzyme in the acidic prelysosomal compartment (1von Figura K. Hasilik A. Annu. Rev. Biochem. 1986; 55: 167-193Crossref PubMed Scopus (636) Google Scholar, 1991; PubMed Scopus Google Scholar). To the ability of the Dom3Ala, and Dom9Ala to dissociate ligand at acidic were affinity the of and Dom9Ala receptors from the at acidic pH of the Dom3Ala receptor was in the acidic pH were the were affinity that were with at pH not These that the Dom3Ala is in ability to dissociate ligand at acidic pH and that the Dom3Ala and Dom9Ala in their ligand MPRs the lysosomal targeting of acid a of enzymes that in of of of their and/or the position of the Man-6-P and to the mannose in the The of the receptor a the of the that of the two Man-6-P binding The of two Man-6-P binding sites in MPRs that the receptors have to two binding sites to target the of acid hydrolases to the lysosome. To the ability of containing a single Man-6-P binding site to target lysosomal enzymes to the lysosome was To of in which a single amino acid substitution in each binding site was shown to Man-6-P binding affinity N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). The substitution of Arg435 in domain Arg1334 in domain 9 N.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar), or in the A. von Figura K. J. Biol. Chem. 1991; Full Text PDF PubMed Google with either or completely Man-6-P that the presence of a at is essential for ligand binding. The structure of the bovine that which with Arg435 and Arg1334 of the Man-6-P Dahms N.M. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar). is that the in domain 3 and domain 9 studies on the is not that the substitutions the binding of Man-6-P-containing and not the or binding of the receptor demonstrated To the ability of mutant to target lysosomal enzymes to the lysosome, mouse L which not were used to stably transfected cell lines and mutant demonstrated that mutant containing a single Man-6-P binding site and were ∼50% the receptor in targeting the of lysosomal enzymes to the lysosome These data the that the IGF-II/MPR two Man-6-P binding sites in to target the of lysosomal enzymes to the lysosome. The in the overall targeting of with Man-6-P binding site to either a in the affinity for lysosomal enzymes or the to bind that with Man-6-P binding site a in the affinity for Man-6-P-containing ligands. in affinity due to the of binding in the mutant receptors that a single Man-6-P binding is that the presence of binding sites in a can to higher binding has been shown for the receptor, the and the mannose receptor K. K. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar, K. Annu. Rev. Biochem. 1996; PubMed Scopus Google Scholar). The of the stably transfected cells that mutant receptors with a Man-6-P binding site in domains 1–3 from receptors with a single Man-6-P binding site in domains in their ability to target lysosomal of the β-hexosaminidase and of which are and the cathepsin D has shown that the of with Man-6-P binding site from enzyme to enzyme and on the of the single Man-6-P binding with a Man-6-P binding site in domains were efficient the receptor in the targeting of cathepsin a that two oligosaccharides Res. PubMed Scopus Google Scholar). In the of cathepsin D in cell lines containing a Man-6-P binding site in domains 1–3 was not from cell lines transfected with of the of a lysosomal that the Dom3Ala and Dom9Ala target enzyme to the lysosome the at higher receptor Dom3Ala was to target β-glucuronidase to a the receptor β-glucuronidase is a and each oligosaccharides of which sites are and Kornfeld S. J. Biol. Chem. Full Text PDF PubMed Google Scholar). β-glucuronidase oligosaccharides that are cathepsin D two data indicate that the ability of the with Man-6-P binding site with the of and on the ligands: the the of the higher the that a mannose in a and for a mutant IGF-II/MPR to which with Man-6-P binding site can target β-glucuronidase than cathepsin These data that have two Man-6-P binding sites to the of a of ligands. studies demonstrated the Dom3Ala and the Dom9Ala in their ability to target lysosomal The most of the two Man-6-P binding sites was in the of β-hexosaminidase β-hexosaminidase is a of a of and which and sites for B. K. 1988; PubMed Scopus Google Scholar, T. J. A. Biochem. J. 1992; PubMed Scopus Google Scholar). enzyme is the Dom3Ala the receptor, the of β-hexosaminidase in cell lines the Dom9Ala was from cell lines transfected with These that the two mutant containing a single Man-6-P binding site in their ability to target lysosomal that the ligand binding of the two recognition domains of the of the mutant and receptor from a affinity that with Man-6-P binding site have a affinity than the receptor for ligand and that the Dom9Ala has a affinity than the Dom3Ala To determine the in binding binding β-glucuronidase demonstrated that the Dom3Ala has a of 2.0 nm, which is to that of the The Dom9Ala has an in affinity in with the Dom3Ala the of the Dom3Ala and Dom9Ala for β-glucuronidase are not from each or that of the receptor in their ability to target enzyme to the lysosome in is from that of the receptor for the in binding affinity that the IGF-II/MPR is The of receptor is are that is a P. B. J. Biol. Chem. Full Text PDF PubMed Google and that is an Braulke T. Hasilik A. von Figura K. Biol. Chem. 1987; PubMed Scopus Google Scholar). the IGF-II/MPR is than the mutant receptors in binding of and the high affinity binding for is that the in binding affinity were the β-glucuronidase used for the in a ligand than the mouse enzyme assayed in β-glucuronidase oligosaccharides on each and is that two sites are J.M. Grubb J.H. Sly W.S. J. Biol. Chem. Full Text PDF PubMed Google Scholar). the β-glucuronidase and each is with the Kornfeld S. J. Biol. Chem. Full Text PDF PubMed Google Scholar). P.Y. Kornfeld S. J. Biol. Chem. 1989; 264: Full Text PDF PubMed Google has shown that the affinity of the IGF-II/MPR for is than the affinity for The in binding studies are with the targeting data in that the has the affinity for β-glucuronidase and is the efficient in targeting enzyme the in affinity is in the of has been shown that a in affinity in can have a on and Lobel Lobel P. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google a in for cathepsin D of and for the IGF-II/MPR and the respectively. the is the targeting of each receptor is the target of their cathepsin D to the lysosome, in contrast to the cells the IGF-II/MPR F. von Figura K. J. Biol. 1996; PubMed Scopus Google Scholar). the Dom3Ala affinity for β-glucuronidase was not from that of the receptor ability to target enzyme in was at of receptor is that in the lysosomal enzyme targeting The targeting of synthesized acid hydrolases the binding and of The complex in the Golgi and is transported to a prelysosomal The low pH of compartment of the complex a in the of the receptor J. Biol. Chem. 1987; Full Text PDF PubMed Google Scholar). in the ability to dissociate ligand can have an overall in the targeting is demonstrated in the of cells with the or which the pH and the The to dissociate ligand in receptors and the of synthesized acid hydrolases A. Grubb J.H. Sly W.S. J. Biol. PubMed Scopus Google Scholar, Braulke T. von Figura K. Hasilik A. Biol. Chem. 1987; PubMed Scopus Google Scholar). indicate that the to low pH is in the Dom3Ala not in the Dom9Ala In with the receptor, of ligand at acidic pH the Dom3Ala a for the in the overall targeting of lysosomal the to which the Dom3Ala and Dom9Ala were from the affinity at pH and indicate that the two Man-6-P binding sites in their ligand and a for the in their ability to target lysosomal enzymes to the lysosome in In containing than Man-6-P binding site are less efficient than the receptor in targeting lysosomal that the IGF-II/MPR has two Man-6-P binding sites to target of and/or to binding and efficient targeting of ligands. The in the ability to target lysosomal enzymes to the lysosome, the affinity of binding and the of ligand that the two Man-6-P binding sites are not functionally equivalent. studies are a of the binding and of the two Man-6-P binding sites of the for and of the

References

48